Participating

What will happen to me if I agree to take part?

If you agree to take part in the study, you will undergo standard mammography or standard mammography plus tomosynthesis screening, according to the study randomisation process.

The tomosynthesis imaging is done at the same time as the standard mammogram. The radiographer will take two x-rays of each breast; one from the side and one from above. The breast remains compressed for approximately 8 more seconds for each view. The mammogram images will be viewed by two film readers who have undergone specialist training in the interpretation of both standard screening and tomosynthesis mammograms. You will be sent a letter informing you of the outcome of your mammography screening within three weeks of your visit.

The National Cancer Registration and Analysis Service (NCRAS) collects information on all patients with cancer in England (http://www.ncras.nhs.uk/). This data is linked to routine hospital records (Hospital Episode Statistics). The Office for Data Release, a part of Public Health England, is responsible for the secure sharing of this data. We would like to ask for your permission to access any data that might be held about you, if you do develop any cancers in the future, by the NCRAS, including your hospital records. We will use this data to help ensure we record any breast cancers diagnosed from women participating in this research study. It will also allow us to estimate the cost of any treatment you might receive on your breasts. To do this, we need your permission to use your name, DOB and NHS number to access this data. This information will be transferred securely from the trial screening centre to the Office for Data Release. They will use it to identify any matching records and return them to us after removing any identifying data.

Data from the NCRAS will be stored on a secure server at the Royal Surrey County Hospital and will be held and used in keeping with the Data Protection Act, 1998. The data will not be shared with any other parties. You are free to participate in the trial without consenting for us to access this data and you may also withdraw your consent at any time should you no longer wish us to access this data.

 

PROSPECTS Trial stages

Individuals are invited to participate in the study through the screening programme. You cannot request to participate.

 

Possible disadvantages and risks of taking part in the study

The tomosynthesis examination involves approximately 8 seconds of additional compression for each of the two views taken of each breast. Some women experience mild or moderate discomfort during compression of the breast for a mammogram.

 

Radiation

X-ray mammography involves the use of a small dose of radiation. Tomosynthesis involves an additional dose of radiation roughly equivalent to that of a standard mammogram. Participation in the study would be equivalent to having two mammograms in a row. This has been considered by our radiation protection advisors and is not considered to be a significant risk to health.

The radiation dose of a mammogram is approximately equivalent to eight months of the normal background radiation we are all exposed to. The additional risk of causing a breast cancer in women participating in the trial who undergo tomosynthesis and standard 2D mammography is estimated as 1 in 29,000.

 

Participation Details

If you have received information about the trial in the post, this means you have been invited to participate. You will need to read the information leaflet and sign the consent form if you are happy to join the trial. If you have any further questions this website should provide all the information you need to help you make a decision. If you would have any questions that you cannot find the answer for on this website please call ….?

Not all women who are based at these screening centres will be invited to participate. You will only be able to participate if you have received a invitation letter in the post.

If you are with a breast screening centre that is not one of those listed above, unfortunately you will not be able to join the trial.

There will not be time, staff or facilities available to have any further discussions about the trial when you attend your screening appointment. The time allocation for a mammogram is fairly short and requires out staff to work without interruptions to keep to appointment times for clients. Please contact us on…. if you have any further questions.

Giving your consent to this trial will allow us to allocate you to a either one of two types of breast imaging. You will not be able to know which technique we will perform. You will not be able to choose which technique you would prefer.

Your results will be sent out to you within 2 weeks no matter which technique we use.

If you choose not to consent to join the trial, we will still perform a standard mammogram when you arrive.

 

Are you eligible?

In order to be classified as eligible to take part in this trial, you must meet the following requirements:

  • Aged between 50-70
  • Approved to undergo Trial by GP
  • Received an invitation letter
  • Able to provide informed consent

All eligible women who are to be invited to participate in the trial will be sent written information about the trial. This will be included with the screening invitation letter sent 20-30 days prior to the screening appointment.

 

Consent form:

Download “Consent form” PROSPECTS-Consent-Form_v5.0_13.06.2017.pdf – Downloaded 1351 times – 189.79 KB

Information sheet:

Download “Information sheet” PROSPECTS_PIS_version_2.0_13_06_2017.pdf – Downloaded 1318 times – 370.49 KB

Questionnaire form:

Download “Questionnaire” PROSPECTS-Patient-Questionnaire_23.06.16_v2.pdf – Downloaded 1368 times – 218.17 KB